Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Jernberg

Showing results (191-200 of 345) with videos related to

Pageof 35
Sort By:
Circulation|September 2, 2020
Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome: Insights From the SWEDEHEART RegistryKarolina Szummer, Maria E Montez-Rath, Joakim Alfredsson, et al.
European Heart Journal Open|March 9, 2026
Inflammatory and cholesterol risks and rates of major cardiovascular events among patients with atherosclerotic cardiovascular disease in routine careFaizan Mazhar, Davide Capodanno, Paul Hjemdahl, et al.
Clinical Biochemistry|September 8, 2021
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarctionMarcus Hjort, Kai M Eggers, Lars Lindhagen, et al.
European Heart Journal|April 20, 2006
Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery diseaseTomas Jernberg, Christopher D Payne, Kenneth J Winters, et al.
ESC Heart Failure|February 3, 2023
Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarctionEleonora Hamilton, Liyew Desta, Anna Lundberg, et al.
Journal of the American Heart Association|January 9, 2020
Culprit and Nonculprit Recurrent Ischemic Events in Patients With Myocardial Infarction: Data From SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies)Christoph Varenhorst, Pål Hasvold, Saga Johansson, et al.
Heart (British Cardiac Society)|May 2, 2023
Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomesDivan Ishak, Suleman Aktaa, Lars Lindhagen, et al.
The Lancet Regional Health. Europe|November 11, 2025
Long-acting nitrate use before and after revascularization to evaluate angina in chronic coronary syndrome: a case-crossover study from SCAARSacharias von Koch, Tania Sharma, Ramzi Khamis, et al.
Journal of Diabetes and Its Complications|September 8, 2023
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trialViveca Ritsinger, Emil Hagström, Kristina Hambraeus, et al.
European Heart Journal. Acute Cardiovascular Care|May 14, 2019
Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trialPontus Andell, Stefan James, Ollie Östlund, et al.
Pageof 35

Showing results (191-200 of 345) with videos related to

Sort By:
Pageof 35
Circulation|September 2, 2020
Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome: Insights From the SWEDEHEART RegistryKarolina Szummer, Maria E Montez-Rath, Joakim Alfredsson, et al.
European Heart Journal Open|March 9, 2026
Inflammatory and cholesterol risks and rates of major cardiovascular events among patients with atherosclerotic cardiovascular disease in routine careFaizan Mazhar, Davide Capodanno, Paul Hjemdahl, et al.
Clinical Biochemistry|September 8, 2021
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarctionMarcus Hjort, Kai M Eggers, Lars Lindhagen, et al.
European Heart Journal|April 20, 2006
Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery diseaseTomas Jernberg, Christopher D Payne, Kenneth J Winters, et al.
ESC Heart Failure|February 3, 2023
Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarctionEleonora Hamilton, Liyew Desta, Anna Lundberg, et al.
Journal of the American Heart Association|January 9, 2020
Culprit and Nonculprit Recurrent Ischemic Events in Patients With Myocardial Infarction: Data From SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies)Christoph Varenhorst, Pål Hasvold, Saga Johansson, et al.
Heart (British Cardiac Society)|May 2, 2023
Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomesDivan Ishak, Suleman Aktaa, Lars Lindhagen, et al.
The Lancet Regional Health. Europe|November 11, 2025
Long-acting nitrate use before and after revascularization to evaluate angina in chronic coronary syndrome: a case-crossover study from SCAARSacharias von Koch, Tania Sharma, Ramzi Khamis, et al.
Journal of Diabetes and Its Complications|September 8, 2023
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trialViveca Ritsinger, Emil Hagström, Kristina Hambraeus, et al.
European Heart Journal. Acute Cardiovascular Care|May 14, 2019
Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trialPontus Andell, Stefan James, Ollie Östlund, et al.
Pageof 35